|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zhang S, Zeng H, Xia C,
Zuo T, Yang Z, Zou X and He J: Cancer incidence and mortality in
China, 2013. Cancer Lett. 401:63–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Massetti GM, Thomas CC, King J, Ragan K
and Buchanan Lunsford N: Mental health problems and cancer risk
factors among young adults. Am J Prev Med. 53(3): Suppl 1:S30–S39.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shan T, Ma J, Ma Q, Guo K, Guo J, Li X, Li
W, Liu J, Huang C, Wang F, et al: β2-AR-HIF-1α: A novel regulatory
axis for stress-induced pancreatic tumor growth and angiogenesis.
Curr Mol Med. 13:1023–1034. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu Q, Zong L, Chen X, Jiang Z, Nan L, Li
J, Duan W, Lei J, Zhang L, Ma J, et al: Resveratrol in the
treatment of pancreatic cancer. Ann NY Acad Sci. 1348:10–19. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vergara D, De Domenico S, Tinelli A,
Stanca E, Del Mercato LL, Giudetti AM, Simeone P, Guazzelli N,
Lessi M, Manzini C, et al: Anticancer effects of novel resveratrol
analogues on human ovarian cancer cells. Mol Biosyst. 13:1131–1141.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zeng YH, Zhou LY, Chen QZ, Li Y, Shao Y,
Ren WY, Liao YP, Wang H, Zhu JH, Huang M, et al: Resveratrol
inactivates PI3K/Akt signaling through upregulating BMP7 in human
colon cancer cells. Oncol Rep. 38:456–464. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yan Y, Zhou C, Li J, Chen K, Wang G, Wei
G, Chen M and Li X: Resveratrol inhibits hepatocellular carcinoma
progression driven by hepatic stellate cells by targeting Gli-1.
Mol Cell Biochem. 434:17–24. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saunier E, Antonio S, Regazzetti A, Auzeil
N, Laprévote O, Shay JW, Coumoul X, Barouki R, Benelli C, Huc L, et
al: Resveratrol reverses the Warburg effect by targeting the
pyruvate dehydrogenase complex in colon cancer cells. Sci Rep.
7:69452017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bai Y, Yang H, Zhang G, Hu L, Lei Y, Qin
Y, Yang Y, Wang Q, Li R and Mao Q: Inhibitory effects of
resveratrol on the adhesion, migration and invasion of human
bladder cancer cells. Mol Med Rep. 15:885–889. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferraresi A, Phadngam S, Morani F, Galetto
A, Alabiso O, Chiorino G and Isidoro C: Resveratrol inhibits
IL-6-induced ovarian cancer cell migration through epigenetic
up-regulation of autophagy. Mol Carcinog. 56:1164–1181. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Deus CM, Serafim TL, Magalhães-Novais S,
Vilaça A, Moreira AC, Sardão VA, Cardoso SM and Oliveira PJ:
Sirtuin 1-dependent resveratrol cytotoxicity and
pro-differentiation activity on breast cancer cells. Arch Toxicol.
91:1261–1278. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu Y, Zhao X, Zhang Y, Kang Y, Wang J and
Liu Y: Antitumor activity of YM155, a selective survivin
suppressant, in combination with cisplatin in hepatoblastoma. Oncol
Rep. 34:407–414. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kostev K, Jacob L and Kalder M: Risk of
depression, anxiety, and adjustment disorders in women with a
suspected but unconfirmed diagnosis of breast or genital organ
cancer in Germany. Cancer Causes Control. 28:1021–1026. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dzebo S, Mahmutovic J, Erkocevic H and
Foco F: Frequency of depression and its correlation with quality of
life of patients with oral cavity cancer. Mater Sociomed.
29:97–100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gonzalez-Saenz de Tejada M, Bilbao A, Baré
M, Briones E, Sarasqueta C, Quintana JM and Escobar A: CARESS-CCR
Group: Association between social support, functional status, and
change in health-related quality of life and changes in anxiety and
depression in colorectal cancer patients. Psychooncology.
26:1263–1269. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jia Y, Li F, Liu YF, Zhao JP, Leng MM and
Chen L: Depression and cancer risk: A systematic review and
meta-analysis. Public Health. 149:138–148. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vilardi BM, Bravo-Calderón DM, Bernabé DG,
Oliveira SH and Oliveira DT: VEGF-C expression in oral cancer by
neurotransmitter-induced activation of beta-adrenergic receptors.
Tumour Biol. 34:139–143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang XY, Wang HC, Yuan Z, Huang J and
Zheng Q: Norepinephrine stimulates pancreatic cancer cell
proliferation, migration and invasion via β-adrenergic
receptor-dependent activation of P38/MAPK pathway.
Hepatogastroenterology. 59:889–893. 2012.PubMed/NCBI
|
|
20
|
Zhang D, Ma QY, Hu HT and Zhang M:
β2-adrenergic antagonists suppress pancreatic cancer cell invasion
by inhibiting CREB, NFκB and AP-1. Cancer Biol Ther. 10:19–29.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang Z, Chen X, Chen K, Sun L, Gao L,
Zhou C, Lei M, Duan W, Wang Z, Ma Q, et al: YAP inhibition by
resveratrol via activation of AMPK enhances the sensitivity of
pancreatic cancer cells to gemcitabine. Nutrients. 8:E5462016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tomas-Hernández S, Blanco J, Rojas C,
Roca-Martínez J, Ojeda-Montes MJ, Beltrán-Debón R, Garcia-Vallve S,
Pujadas G, Arola L and Mulero M: Resveratrol potently counteracts
quercetin starvation-induced autophagy and sensitizes HepG2 cancer
cells to apoptosis. Mol Nutr Food Res. 62:2018. View Article : Google Scholar
|
|
23
|
De Francesco EM, Maggiolini M and Musti
AM: Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT.
Int J Mol Sci. 19:E20112018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schito L and Semenza GL: Hypoxia-inducible
factors: Master regulators of cancer progression. Trends Cancer.
2:758–770. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun Y, Wang H, Liu M, Lin F and Hua J:
Resveratrol abrogates the effects of hypoxia on cell proliferation,
invasion and EMT in osteosarcoma cells through downregulation of
the HIF-1α protein. Mol Med Rep. 11:1975–1981. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Barbieri A, Bimonte S, Palma G, Luciano A,
Rea D, Giudice A, Scognamiglio G, La Mantia E, Franco R, Perdonà S,
et al: The stress hormone norepinephrine increases migration of
prostate cancer cells in vitroin vivo. Int J Oncol.
47:527–534. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang LP, Jin J, Lv FF, Cao J, Zhang J,
Wang BY, Shao ZM, Hu XC and Wang ZH: Norepinephrine attenuates
CXCR4 expression and the corresponding invasion of MDA-MB-231
breast cancer cells via β2-adrenergic receptors. Eur Rev Med
Pharmacol Sci. 19:1170–1181. 2015.PubMed/NCBI
|
|
28
|
Chang CH, Lee CY, Lu CC, Tsai FJ, Hsu YM,
Tsao JW, Juan YN, Chiu HY, Yang JS and Wang CC: Resveratrol-induced
autophagy and apoptosis in cisplatin-resistant human oral cancer
CAR cells: A key role of AMPK and Akt/mTOR signaling. Int J Oncol.
50:873–882. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reddivari L, Charepalli V, Radhakrishnan
S, Vadde R, Elias RJ, Lambert JD and Vanamala JK: Grape compounds
suppress colon cancer stem cells in vitro and in a rodent model of
colon carcinogenesis. BMC Complement Altern Med. 16:2782016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao L, Chen X, Xiao X, Ma Q and Li W:
Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and
migration of pancreatic cancer cells via suppression of the ERK and
p38 MAPK signaling pathways. Int J Oncol. 49:735–743. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Baek SH, Ko JH, Lee H, Jung J, Kong M, Lee
JW, Lee J, Chinnathambi A, Zayed ME, Alharbi SA, et al: Resveratrol
inhibits STAT3 signaling pathway through the induction of SOCS-1:
Role in apoptosis induction and radiosensitization in head and neck
tumor cells. Phytomedicine. 23:566–577. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cui X, Jin Y, Hofseth AB, Pena E, Habiger
J, Chumanevich A, Poudyal D, Nagarkatti M, Nagarkatti PS, Singh UP
and Hofseth LJ: Resveratrol suppresses colitis and colon cancer
associated with colitis. Cancer Prev Res. 3:549–559. 2010.
View Article : Google Scholar
|
|
33
|
León D, Uribe E, Zambrano A and Salas M:
Implications of resveratrol on glucose uptake and metabolism.
Molecules. 22:E3982017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liang X, Bi S, Yang W, Wang L, Cui G, Cui
F, Zhang Y, Liu J, Gong X, Chen Y, et al: Reprint of:
Epidemiological serosurvey of Hepatitis B in China - declining HBV
prevalence due to Hepatitis B vaccination. Vaccine. 31 Suppl
9:J21–J28. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Casciano JC and Bouchard MJ: Hepatitis B
virus X protein modulates cytosolic Ca2+ signaling in
primary human hepatocytes. Virus Res. 246:23–27. 2018. View Article : Google Scholar : PubMed/NCBI
|
